Research and experimental development on natural sciences and engineering
KLYV THERAPEUTICS AS
Revenue 2024
NOK 935,000
Operating profit
NOK 161,000
Equity
NOK 718,000
Incorporated
2023
Share capital
NOK 122,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 935k | |
| Total operating costs | 773k | |
| Operating profit (EBIT) | 161k | |
| Net financial items | −4k | |
| Profit for the year | 123k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 934k | |
| of which current assets | 934k | |
| Equity | 718k | |
| Total liabilities | 217k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.